Acción 8189 TIANJIN TEDA BIOMEDICAL ENGINEERING COMPANY LIMITED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Tianjin TEDA Biomedical Engineering Company Limited

Acciones

8189

CNE1000004H7

Mercado cerrado - Hong Kong S.E.
Otros sitios de cotización
 10:09:00 03/05/2024 		Varia. Cinco días. Varia. 1 de enero.
0,075 HKD 0,00 % Gráfico intradía de Tianjin TEDA Biomedical Engineering Company Limited 0,00 % -15,73 %
28/03 Tianjin TEDA Biomedical Engineering Company Limited presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI
28/03 Tianjin TEDA Biomedical Engineering Company Limited anuncia la dimisión del Sr. Li Xudong como Director no ejecutivo independiente y Presidente del Comité de Auditoría CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Tianjin TEDA Biomedical Engineering Company Limited Announces Resignation of Mr. Li Xudong as Independent Non-Executive Director and Chairman of the Audit Committee
An undisclosed buyer agreed to acquire an unknown stake in Shanghai Weidi Network Technology Company Limited from Tianjin TEDA Biomedical Engineering Company Limited
Tianjin TEDA Biomedical Engineering Company Limited Announces Chief Executive Officer Changes
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tianjin TEDA Biomedical Engineering Company Limited Announces Change of Principal Place of Business in Hong Kong
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Tianjin TEDA Biomedical Engineering Company Limited Announces Mr. Hao Zhihui Will Retire as an Executive Director
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Tianjin Teda Biomedical Engineering Company Limited Announces Executive Changes
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Tianjin TEDA Biomedical Engineering Company Limitedcompleted the acquisition of Shanghai Weidi Network Technology Company from three shareholders.
Tianjin TEDA Biomedical Engineering Company Limited entered into the Equity Transfer Agreement to acquire Shanghai Weidi Network Technology Company from three shareholders for CNY12.8 million.
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Tianjin Teda Biomedical Engineering Company Limited Announces Delay in Publication and Despatch of Annual Report for the Year
Tianjin TEDA Biomedical Engineering Company Limited Approves Appointment of Mr. Zhao Zhiyou as the Independent Supervisor
Wang Shuxin entered into the Equity Transfer Agreement to acquire 30.2653% stake in Tianjin Alpha Healthcare Products Co., Ltd. from Tianjin TEDA Biomedical Engineering Company Limited for CNY 10.86 million.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 8189
  4. Noticias Tianjin TEDA Biomedical Engineering Company Limited
  5. Otros idiomas